Showing results (651-660 of 1,074) with videos related to

Sort By:
Pageof 108
JACC. Cardiovascular Interventions|August 5, 2019
Effects of Methylnaltrexone on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients Treated With MorphineFrancesco Franchi, Fabiana Rollini, Yongwhi Park, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 18, 2013
Usefulness of the logistic clinical SYNTAX score for predicting 1-year mortality in patients undergoing percutaneous coronary intervention of the left main coronary arteryDavide Capodanno, Daniele Giacoppo, Fabio Dipasqua, et al.
Giornale Italiano Di Cardiologia (2006)|July 11, 2018
[Dual antiplatelet therapy in elderly patients with acute coronary syndrome: does age make the difference?]Giuseppe Tarantini, Plinio Cirillo, Stefano De Servi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 13, 2012
Effect of renal artery stenting on left ventricular mass: a randomized clinical trialCarmelita Marcantoni, Luca Zanoli, Stefania Rastelli, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 18, 2025
Dual antiplatelet therapy de-escalation by discontinuation in patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysisMarco Spagnolo, Claudio Laudani, Antonino Imbesi, et al.
Journal of the American College of Cardiology|September 2, 2025
Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,592 patientsMattia Galli, Stefano Benenati, Claudio Laudani, et al.
Journal of the American College of Cardiology|October 8, 2021
Bridging Antiplatelet Therapy After Percutaneous Coronary Intervention: JACC Review Topic of the WeekAlexander E Sullivan, Michael G Nanna, Tracy Y Wang, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 21, 2009
Strategies for drug-eluting stent treatment of bifurcation coronary artery disease in the United States: insights from the e-Cypher S.T.L.L.R.trialNobuaki Suzuki, Dominick J Angiolillo, Mark A Tannenbaum, et al.
Pageof 108